Abstract In the present study, we aim to prospectively evaluate the effect of performing rigid cystoscopy (CPE) in urological patients on the total serum prostate-specific antigen (PSA) levels. The study design was a prospective observational study. After giving informed consent, urological patients visiting the outpatient clinic of our institution from
Introduction
Serum prostate-specific antigen (PSA) is produced by benign/malignant prostatic epithelial cells and serves to cause liquefaction of the seminal fluid [1] , and disruption of cellular architecture within the prostate gland can increase PSA levels [2] . Although present in large amount in prostate tissue and semen, PSA has also been detected in other body fluids and tissues. Serum PSA levels may be elevated in prostate diseases, prostatic manipulations, and urological diagnostic and therapeutic procedures. Since PSA estimation is frequently used in conjunction with digital rectal exam (DRE) for early diagnosis and management of prostate cancer, it is used as a tumor marker for early detection, screening, staging, and posttreatment monitoring of patients with suspected prostate cancer. Thus, it is necessary to study the effect of various factors (CPE) on serum PSA levels that may impact its interpretation. The precise impact of CPE on serum PSA is also not well defined in the literature. In this study, we attempt to prospectively evaluate the effect, if any, of rigid cystoscopy on the serum PSA levels in urological patients. We believe this may help in better interpretation of false positives in patients with elevated serum PSA levels. To the best of our knowledge, we could not locate any similar Indian study in the published English literature (PubMed   TM   ) . This forms the rationale for undertaking the present study.
Methods
After obtaining institutional ethics clearance and administering an informed consent, a prospective observational study was undertaken in the outpatient clinic of our institution from November 2010 to March 2012. Patients satisfying our entry criteria (all adults 40-80 years of age with urological complaints warranting a cystoscopy) were enrolled into the current study. Patients with active or untreated urinary tract infection, recent history of sexual activity/ejaculation in the preceding 1 week, history of drug therapy (antiandrogens and/or alphablockers), history of transurethral resection of the prostate (TURP) and prostatic biopsy in the preceding 6 weeks, history of DRE in the preceding 1 week, and patients with diagnosed prostate cancer were excluded from the present study. Venous blood (2 ml) was withdrawn 1 h prior to cystoscopy and was sent for serum PSA assay. About 10 ml of 2 % xylocaine jelly was pushed through the meatus. Diagnostic rigid cystoscopy was performed using a 17-Fr compact-type rigid cystoscope in OT in the usual manner. After performing rigid cystoscopy, 2 ml of venous blood was again withdrawn 1 and 24 h after the cystoscopy. All blood samples withdrawn were sent for serum total PSA estimation.
The specimens were centrifuged to separate the serum from the cells and stored at 2-8°C till assay. All serum samples were assayed within 48-72 h of their being withdrawn. All samples were quantitatively analyzed by a microplate immunoenzymometric technique using an enzymelinked immunosorbent assay (ELISA) kit (Weldon Biotech) [3, 4] . Each ELISA titer plate contained 96 wells for PSA testing. The standard laboratory reference range for serum PSA of 0-4.0 ng/ml was used in this study. Statistical significance of differences between means of total serum PSA levels was determined by Student's t test, and paired t test was used to compare serum PSA levels before and at 1/24 h after cystoscopy. P<0.05 was considered to be statistically significant. In patients with serum PSA levels >4 ng/ml, prostatic biopsy was performed to rule out prostate cancer. All the patients were found to be negative for prostate cancer and had evidence of benign prostatic hyperplasia (BPH).
Results
Our study was conducted on a total of 50 patients (40-80 years with mean age of 60 years) with urological complaints for which cystoscopy was warranted in 19, 14, 9, 8, and 1 patient for evaluation of BPH, hematuria, urethral Tables 1 to 3 . The serum total PSA (tPSA) was measured before (0 h) and 1 and 24 h after performing rigid cystoscopy. Serum tPSA at 0 h was 0.02-12.33 ng/ml (mean, 1.9820± 2.25989), whereas the serum tPSA was 0.3-14.26 ng/ml (mean, 2.9004±2.8198) 1 h after cystoscopy and 0.2-15.03 ng/ml (mean, 3.0488±2.95127) 24 h after CPE, as depicted in Table 1 .
The mean serum tPSA values at 0 and 1 h following cystoscopy were compared using two-tailed paired t test to find out the significance of differences between the values, and a mean rise of −0.91840 was noted in serum PSA value, as depicted in Table 2 .
The change in serum PSA value at 1 h after rigid cystoscopy was found to be highly significant as the P value was 0.000 (P<0.05). Serum PSA value at 0 h was compared with PSA at 24 h following cystoscopy, and the mean change of −1.06680 was noted in serum PSA values which was found to be highly significant as the P value was 0.000 (P<0.05), as shown in Table 3 . A summary depiction of the effect of CPE on serum PSA levels is given in Fig. 1 .
Discussion
Although PSA is mainly present in the prostate tissue and semen, it has also been detected in malignant breast tumors [5] [6] [7] , normal breast tissue [8] , breast milk [9] , and adrenal and renal carcinomas [10] . Serum PSA levels may be increased in BPH [11, 12] , prostatitis [12] , prostate cancer [13] , and following prostate biopsy/massage [14] , DRE [15, 16] , colonoscopy [17] , and cystoscopy [18] . Serum PSA has been traditionally used as a diagnostic tool in conjunction with DRE for the early diagnosis and management of prostate cancer. Studies on the effect of ejaculation on serum PSA have shown either insignificant change [19] or a significant decrease in serum PSA [20, 21] in younger patients, whereas they showed an increase in serum PSA in older patients [22, 23] . Finasteride (5 mg) and other 5-α-reductase inhibitors have been shown to lower PSA levels by an average of 50 % after 6 months of treatment [24] .
Therefore, interpretation of PSA levels should always consider the presence of prostate diseases, previous diagnostic and therapeutic procedures, and prostate-directed treatments because these may alter serum PSA levels. Data from prior studies evaluating PSA change in relation to Table 3 Statistical comparison of total serum PSA levels at 0 and 24 h post CPE cystoscopy have shown variable results, as serum PSA level may either increase or remain the same following cystoscopy. We believe, while it is well accepted, that no urologist may consider an elevated PSA after CPE to be pathological; nevertheless, there is scarcity in published studies evaluating the precise effect of rigid cystoscopy on serum PSA levels, as a recent review of literature suggests that the serum PSA level may increase or remain unaltered following rigid cystoscopy (Table 4 ) [18, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . While the effect of rigid cystoscopy on serum PSA has not been clearly defined in the published literature (Table 4) , in our study, we observed a significant rise in the serum PSA levels both at 1 and 24 h following cystoscopy. Urological conditions necessitating cystoscopy may alter the levels of serum PSA, and we believe that this ought to be taken into consideration while evaluating serum PSA levels for diagnosis of any prostate disease (BPH, prostate cancer) in order to avoid false positives. The current study demonstrated a rise in serum PSA levels at 1 and 24 h following rigid cystoscopy. This increase in serum PSA was seen to be statistically highly significant with a P value of 0.000 (P<0.05). Therefore, we believe that one should postpone the estimation of serum PSA levels by at least 24 h particularly in patients with a history of recent cystoscopy in the previous 24-48 h. The present study was limited by its small size and by lack of symptomwise stratification of patients with various urological disorders, as we believe that these too may have impacted the serum PSA levels.
